$8.03 Billion is the total value of HHLR ADVISORS, LTD.'s 54 reported holdings in Q4 2019. The portfolio turnover from Q3 2019 to Q4 2019 was 34.4% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
IQ | Sell | IQIYI INCsponsored ads | $985,724,000 | +21.0% | 46,694,629 | -7.6% | 12.28% | +9.6% |
BGNE | BEIGENE LTDsponsored adr | $907,082,000 | +35.4% | 5,472,259 | 0.0% | 11.30% | +22.7% | |
ALGN | Buy | ALIGN TECHNOLOGY INC | $656,746,000 | +131.9% | 2,353,591 | +50.3% | 8.18% | +110.1% |
TAL | Sell | TAL EDUCATION GROUPsponsored ads | $552,623,000 | +13.4% | 11,465,202 | -19.4% | 6.88% | +2.8% |
ZM | New | ZOOM VIDEO COMMUNICATIONS INcl a | $470,570,000 | – | 6,916,078 | +100.0% | 5.86% | – |
UBER | Buy | UBER TECHNOLOGIES INC | $461,018,000 | +22.7% | 15,501,624 | +25.8% | 5.74% | +11.3% |
BABA | Sell | ALIBABA GROUP HLDG LTDsponsored ads | $419,898,000 | +15.3% | 1,979,716 | -9.1% | 5.23% | +4.5% |
JD | Sell | JD COM INCspon adr cl a | $419,414,000 | -7.8% | 11,905,028 | -26.1% | 5.22% | -16.4% |
ESGR | ENSTAR GROUP LIMITED | $361,558,000 | +8.9% | 1,747,840 | 0.0% | 4.50% | -1.3% | |
PDD | Sell | PINDUODUO INCsponsored ads | $330,145,000 | -8.1% | 8,729,366 | -21.7% | 4.11% | -16.7% |
CBPO | CHINA BIOLOGIC PRODS HLDGS I | $320,185,000 | +1.7% | 2,751,200 | 0.0% | 3.99% | -7.9% | |
BILI | Sell | BILIBILI INCspons ads rep z | $190,210,000 | +5.0% | 10,215,355 | -20.4% | 2.37% | -4.9% |
SE | Sell | SEA LTDsponsored ads | $172,946,000 | -53.3% | 4,300,000 | -64.0% | 2.16% | -57.6% |
FGEN | Buy | FIBROGEN INC | $169,664,000 | +31.0% | 3,955,787 | +12.9% | 2.11% | +18.7% |
BBIO | BRIDGEBIO PHARMA INC | $153,824,000 | +63.3% | 4,388,690 | 0.0% | 1.92% | +48.0% | |
APLS | APELLIS PHARMACEUTICALS INC | $143,249,000 | +27.1% | 4,678,289 | 0.0% | 1.78% | +15.2% | |
MDLZ | MONDELEZ INTL INCcl a | $140,265,000 | -0.4% | 2,546,564 | 0.0% | 1.75% | -9.8% | |
VIE | New | VIELA BIO INC | $124,650,000 | – | 4,591,176 | +100.0% | 1.55% | – |
BPMC | Buy | BLUEPRINT MEDICINES CORP | $120,533,000 | +9.5% | 1,504,599 | +0.4% | 1.50% | -0.8% |
GOSS | GOSSAMER BIO INC | $92,397,000 | -6.9% | 5,911,541 | 0.0% | 1.15% | -15.6% | |
EDU | Sell | NEW ORIENTAL ED & TECH GRP Ispon adr | $73,139,000 | -76.1% | 603,208 | -78.2% | 0.91% | -78.3% |
SNAP | SNAP INCcl a | $72,928,000 | +3.4% | 4,465,885 | 0.0% | 0.91% | -6.3% | |
MYOK | MYOKARDIA INC | $71,135,000 | +39.8% | 975,987 | 0.0% | 0.89% | +26.6% | |
NXTC | NEXTCURE INC | $59,348,000 | +82.6% | 1,053,570 | 0.0% | 0.74% | +65.3% | |
LN | Sell | LINE CORPsponsored adr | $54,958,000 | +26.6% | 1,121,357 | -7.2% | 0.68% | +14.7% |
MLCO | Sell | MELCO RESORTS AND ENTMT LTDadr | $53,122,000 | -37.7% | 2,197,850 | -50.0% | 0.66% | -43.6% |
NFLX | Sell | NETFLIX INC | $44,135,000 | -36.8% | 136,400 | -47.7% | 0.55% | -42.7% |
BEDU | BRIGHT SCHOLAR ED HLDGS LTDsponsored ads | $35,195,000 | -8.7% | 3,985,797 | 0.0% | 0.44% | -17.4% | |
ARVN | ARVINAS INC | $35,145,000 | +90.7% | 855,308 | 0.0% | 0.44% | +73.1% | |
GMAB | GENMAB A Ssponsored ads | $33,495,000 | +10.2% | 1,500,000 | 0.0% | 0.42% | -0.2% | |
ZLAB | ZAI LAB LTDadr | $33,189,000 | +28.6% | 798,001 | 0.0% | 0.41% | +16.3% | |
SDC | Sell | SMILEDIRECTCLUB INC | $25,329,000 | -37.6% | 2,898,086 | -0.9% | 0.32% | -43.4% |
GTHX | G1 THERAPEUTICS INC | $25,093,000 | +16.0% | 949,431 | 0.0% | 0.31% | +5.4% | |
MOGU | MOGU INCspon ads | $23,818,000 | -9.3% | 10,446,970 | 0.0% | 0.30% | -17.7% | |
KNSA | Buy | KINIKSA PHARMACEUTICALS LTD | $20,969,000 | +31.9% | 1,895,888 | +1.5% | 0.26% | +19.7% |
AKRO | Buy | AKERO THERAPEUTICS INC | $19,780,000 | +16.0% | 891,201 | +18.9% | 0.25% | +5.1% |
RGNX | REGENXBIO INC | $18,682,000 | +15.1% | 456,000 | 0.0% | 0.23% | +4.5% | |
QCOM | New | QUALCOMM INC | $17,646,000 | – | 200,000 | +100.0% | 0.22% | – |
UXIN | Sell | UXIN LTDads | $16,372,000 | -29.2% | 7,244,341 | -23.3% | 0.20% | -35.8% |
IGMS | IGM BIOSCIENCES INC | $13,356,000 | +115.0% | 350,000 | 0.0% | 0.17% | +95.3% | |
HOOK | HOOKIPA PHARMA INC | $11,536,000 | +63.1% | 943,254 | 0.0% | 0.14% | +48.5% | |
EIDX | EIDOS THERAPEUTICS INC | $10,250,000 | +59.6% | 178,600 | 0.0% | 0.13% | +45.5% | |
SOHU | SOHU COM LTDsponsored ads | $8,967,000 | +10.0% | 802,034 | 0.0% | 0.11% | 0.0% | |
CJJD | CHINA JO-JO DRUGSTORES INC | $8,809,000 | +50.4% | 4,840,000 | 0.0% | 0.11% | +35.8% | |
MRUS | New | MERUS N V | $8,448,000 | – | 600,000 | +100.0% | 0.10% | – |
ARGX | New | ARGENX SEsponsored adr | $8,026,000 | – | 50,000 | +100.0% | 0.10% | – |
RCUS | ARCUS BIOSCIENCES INC | $7,748,000 | +11.0% | 767,128 | 0.0% | 0.10% | +1.0% | |
AMG | New | AFFILIATED MANAGERS GROUP IN | $6,046,000 | – | 71,345 | +100.0% | 0.08% | – |
TXG | 10X GENOMICS INC | $5,719,000 | +51.3% | 75,000 | 0.0% | 0.07% | +36.5% | |
TCRR | TCR2 THERAPEUTICS INC | $4,611,000 | -5.0% | 322,903 | 0.0% | 0.06% | -14.9% | |
CBMG | CELLULAR BIOMEDICINE GROUP I | $3,820,000 | +9.3% | 235,214 | 0.0% | 0.05% | 0.0% | |
CIH | CHINA INDEX HLDGS LTDspnsrd ads a | $1,092,000 | -6.7% | 300,000 | 0.0% | 0.01% | -12.5% | |
NEW | PUXIN LTDads | $1,034,000 | +2.9% | 126,145 | 0.0% | 0.01% | -7.1% | |
SFUN | FANG HLDGS LTDadr new | $858,000 | +28.8% | 300,000 | 0.0% | 0.01% | +22.2% | |
NTGN | Exit | NEON THERAPEUTICS INC | $0 | – | -60,000 | -100.0% | -0.00% | – |
GSAHWS | Exit | GS ACQUISITION HLDGS CORP*w exp 06/12/202 | $0 | – | -333,333 | -100.0% | -0.01% | – |
CNST | Exit | CONSTELLATION PHARMCETICLS I | $0 | – | -246,883 | -100.0% | -0.02% | – |
WUBA | Exit | 58 COM INCspon adr rep a | $0 | – | -57,964 | -100.0% | -0.04% | – |
NOAH | Exit | NOAH HLDGS LTDspon ads cl a | $0 | – | -481,220 | -100.0% | -0.19% | – |
MRNA | Exit | MODERNA INC | $0 | – | -978,434 | -100.0% | -0.21% | – |
MELI | Exit | MERCADOLIBRE INC | $0 | – | -32,600 | -100.0% | -0.25% | – |
HTHT | Exit | HUAZHU GROUP LTDsponsored ads | $0 | – | -611,490 | -100.0% | -0.28% | – |
NIO | Exit | NIO INCspon ads | $0 | – | -13,368,900 | -100.0% | -0.29% | – |
SQ | Exit | SQUARE INCcl a | $0 | – | -428,675 | -100.0% | -0.36% | – |
AAPL | Exit | APPLE INC | $0 | – | -127,759 | -100.0% | -0.39% | – |
TSLA | Exit | TESLA INC | $0 | – | -171,400 | -100.0% | -0.57% | – |
MOMO | Exit | MOMO INCadr | $0 | – | -1,385,000 | -100.0% | -0.59% | – |
CVET | Exit | COVETRUS INC | $0 | – | -3,958,198 | -100.0% | -0.65% | – |
AMZN | Exit | AMAZON COM INC | $0 | – | -48,456 | -100.0% | -1.16% | – |
FB | Exit | FACEBOOK INCcl a | $0 | – | -1,280,763 | -100.0% | -3.14% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-02-14
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
BEIGENE LTD | 20 | Q3 2023 | 26.0% |
JD.COM INC | 20 | Q3 2023 | 13.1% |
IQIYI INC | 20 | Q3 2023 | 12.3% |
MONDELEZ INTL INC | 20 | Q3 2023 | 5.9% |
KINIKSA PHARMACEUTICALS LTD | 20 | Q3 2023 | 1.6% |
SOHU COM LTD | 20 | Q3 2023 | 0.6% |
PINDUODUO INC | 19 | Q3 2023 | 16.1% |
GOSSAMER BIO INC | 19 | Q3 2023 | 2.3% |
BRIDGEBIO PHARMA INC | 18 | Q3 2023 | 3.4% |
MELCO RESORTS AND ENTMT LTD | 18 | Q1 2023 | 2.8% |
View HHLR ADVISORS, LTD.'s complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
I-Mab | June 30, 2023 | 15,891,211 | 8.3% |
BeiGene, Ltd. | February 14, 2023 | 147,043,058 | 10.9% |
Gossamer Bio, Inc. | February 14, 2023 | 4,974,041 | 5.3% |
On Holding AG | February 14, 2023 | 5,468,504 | 1.9% |
Root, Inc. | February 14, 2023 | 138,977 | 1.5% |
Yatsen Holding Ltd | February 14, 2023 | 300,560,602 | 19.1% |
iQIYI, Inc. | July 11, 2022 | 149,075,912 | 5.0% |
Apellis Pharmaceuticals, Inc. | February 14, 2022 | ? | ? |
Beam Therapeutics Inc. | February 14, 2022 | ? | ? |
Futu Holdings Ltd | February 14, 2022 | 2 | - |
View HHLR ADVISORS, LTD.'s complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
4 | 2024-02-01 |
13F-HR | 2023-11-14 |
View HHLR ADVISORS, LTD.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.